Surface Neutralization System - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Surface Neutralization System
A new, robust method for protein elution from ceramic hydroxyapatite.

Pharmaceutical Technology
Volume 35, Issue 9, pp. 66-72


1. L.J. Cummings, T. Ogawa, and P. Tunón, "CHT Ceramic Hydroxyapatite: New Life for an Old Chromatographic Technique," Bulletin No. 1927 Rev. B (Bio-Rad Laboratories, Hercules, CA, 2005).

2. P. Yachelini, I. Falk, and K. Eichmann, J. Immunol. 145 (5), 1382–1389 (1990).

3. K. Schott et al., J. Biol. Chem. 265 (8), 4204–4209 (1990).

4. C.W. Mahoney, A. Azzi, and K.P. Huang, J. Biol. Chem. 265 (10), 5424–5428 (1990).

5. A.C. Newton and D.E. Koshland Jr., Biochemistry 29 (28), 6656–6661 (1990).

6. B.R. Ganong, Biochemistry 29 (29), 6904–6910 (1990).

7. L.J. Cummings, M.A. Snyder, and K. Brisack, Meth. Enzymol. 463, 387–404 (2009).

8. K. Y. Kwon et al., J. Phys. Chem. Lett. C, 113 (9), 3369–3372 (2009).

9. L. Dattolo, E.L. Keller and G. Carta, J. Chrom. A. 1217 (48), 7573–7578 (2010).

10. M.A. Snyder, presentation at The Fifth Hydoxyapatite Conference (Rottach-Egern, Germany, 2009).

11. L.J. Cummings, presentation at The Fifth Hydoxyapatite Conference (Rottach-Egern, Germany, 2009).

12. CHT Ceramic Hydroxyapatite Instruction Manual, Bulletin LIT611 Rev. E (Bio-Rad Laboratories, Hercules, CA, 2006).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here